Baudax Bioinc Stock Number Of Employees
| BXRX Stock | USD 0.01 0.0006 5.66% |
Baudax BioInc fundamentals help investors to digest information that contributes to Baudax BioInc's financial success or failures. It also enables traders to predict the movement of Baudax Stock. The fundamental analysis module provides a way to measure Baudax BioInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Baudax BioInc stock.
Baudax | Number Of Employees |
Baudax BioInc Company Number Of Employees Analysis
Baudax BioInc's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Baudax BioInc Number Of Employees | 9 |
Most of Baudax BioInc's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Baudax BioInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Baudax Number Of Employees Driver Correlations
Understanding the fundamental principles of building solid financial models for Baudax BioInc is extremely important. It helps to project a fair market value of Baudax Stock properly, considering its historical fundamentals such as Number Of Employees. Since Baudax BioInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Baudax BioInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Baudax BioInc's interrelated accounts and indicators.
Click cells to compare fundamentals
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Baudax BioInc is currently employing 9.0 people. This is 99.92% lower than that of the Biotechnology sector and 98.32% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.95% higher than that of the company.
Baudax Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Baudax BioInc's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Baudax BioInc could also be used in its relative valuation, which is a method of valuing Baudax BioInc by comparing valuation metrics of similar companies.Baudax BioInc is currently under evaluation in number of employees category among related companies.
Baudax Fundamentals
| Return On Equity | -47.04 | ||||
| Return On Asset | -1.15 | ||||
| Operating Margin | (27.60) % | ||||
| Current Valuation | 17.72 M | ||||
| Shares Outstanding | 43.59 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 2.68 % | ||||
| Number Of Shares Shorted | 493.56 K | ||||
| Price To Earning | 0.03 X | ||||
| Price To Book | 0.68 X | ||||
| Price To Sales | 0.75 X | ||||
| Revenue | 1.27 M | ||||
| Gross Profit | (5.74 M) | ||||
| EBITDA | (34.76 M) | ||||
| Net Income | (7.15 M) | ||||
| Cash And Equivalents | 5.65 M | ||||
| Cash Per Share | 0.28 X | ||||
| Total Debt | 7.12 M | ||||
| Debt To Equity | 2.26 % | ||||
| Current Ratio | 0.53 X | ||||
| Book Value Per Share | (0.84) X | ||||
| Cash Flow From Operations | (14.31 M) | ||||
| Short Ratio | 0.19 X | ||||
| Earnings Per Share | (94.13) X | ||||
| Target Price | 24.0 | ||||
| Beta | 1.58 | ||||
| Market Capitalization | 950.33 K | ||||
| Total Asset | 10.03 M | ||||
| Retained Earnings | (190.9 M) | ||||
| Working Capital | (15.11 M) | ||||
| Current Asset | 21.72 M | ||||
| Current Liabilities | 7.92 M | ||||
| Net Asset | 10.03 M |
About Baudax BioInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Baudax BioInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baudax BioInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baudax BioInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Baudax BioInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Baudax BioInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baudax BioInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Baudax Stock
| 0.64 | EGRX | Eagle Pharmaceuticals | PairCorr |
Moving against Baudax Stock
| 0.75 | SNDL | SNDL Inc Financial Report 20th of May 2024 | PairCorr |
| 0.73 | IMCC | Im Cannabis Corp | PairCorr |
| 0.72 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
| 0.67 | QLI | Qilian International | PairCorr |
| 0.62 | PAHC | Phibro Animal Health Fiscal Year End 4th of September 2024 | PairCorr |
The ability to find closely correlated positions to Baudax BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Baudax BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Baudax BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Baudax BioInc to buy it.
The correlation of Baudax BioInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Baudax BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Baudax BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Baudax BioInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Baudax BioInc Piotroski F Score and Baudax BioInc Altman Z Score analysis. For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Baudax Stock analysis
When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (94.13) | Revenue Per Share 0.318 | Quarterly Revenue Growth (0.23) | Return On Assets (1.15) | Return On Equity (47.04) |
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.